Myocardial infarction
The role of anti-inflammatory drugs and nanoparticle-based drug delivery models in the management of ischemia-induced heart failure
Keywords
- Anti-inflammatory agents
- Heart failure
- Left ventricular remodeling
- Local anti-inflammatory drug delivery
- Multi-modal drug delivery
- Myocardial infarction
- Nanoparticle-based drug delivery
Insulin-like growth factor-1 (IGF-1) poly (lactic-co-glycolic acid) (PLGA) microparticles – development, characterisation, and in vitro assessment of bioactivity for cardiac applications